Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy.

about

Ticagrelor in modern cardiology - an up-to-date review of most important aspects of ticagrelor pharmacotherapy.

Item

http://www.wikidata.org/entity/Q48344587

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Ticagrelor in modern cardiolog ...... of ticagrelor pharmacotherapy.

@en

Ticagrelor in modern cardiolog ...... of ticagrelor pharmacotherapy.

@nl

type

Item

label

Ticagrelor in modern cardiolog ...... of ticagrelor pharmacotherapy.

@en

Ticagrelor in modern cardiolog ...... of ticagrelor pharmacotherapy.

@nl

prefLabel

Ticagrelor in modern cardiolog ...... of ticagrelor pharmacotherapy.

@en

Ticagrelor in modern cardiolog ...... of ticagrelor pharmacotherapy.

@nl

P1476

Ticagrelor in modern cardiolog ...... of ticagrelor pharmacotherapy.

@en

P2093

Franciszek Główka

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysis.

The clinical efficacy and safety evaluation of ticagrelor for acute coronary syndrome in general ACS patients and diabetic patients: A systematic review and meta-analysis.

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study.

Absorption, distribution, metabolism, and excretion of ticagrelor in healthy subjects.

First analysis of the relation between CYP2C19 genotype and pharmacodynamics in patients treated with ticagrelor versus clopidogrel: the ONSET/OFFSET and RESPOND genotype studies.

P304

103-112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/14656566.2017.1421634

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dorota Danielak

Marta Karaźniewicz-Łada

P577

2017-12-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29280403

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy